Skip to main navigation
Skip to search
Skip to main content
Xi'an Jiaotong-Liverpool University Home
Home
Profiles
Research units
Research output
Projects
Activities
Search by expertise, name or affiliation
©
copyrightStatement
View Scopus Profile
Xin Liu
Assistant Professor
AoPHA Faculty
Phone
+86 (0)512 81889033
Email
Xin.Liu
xjtlu.edu
cn
h-index
861
Citations
7
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2008
2024
Research activity per year
Overview
Fingerprint
Network
Projects
(9)
Research output
(18)
Activities
(1)
Similar Profiles
(4)
Fingerprint
Dive into the research topics where Xin Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Drug Discovery
45%
Virtual Screening
22%
Drug Repositioning
22%
Malignant Neoplasm
16%
Tamsulosin
16%
Clinical Trial
14%
Disease
14%
Toxicity
14%
Quantitative Structure-Activity Relationship
14%
Elimination
12%
Natural Product
12%
Lead
12%
Drug Delivery System
11%
Adverse Drug Reaction
11%
Quantitative Structure-Activity Relationship
11%
High-Throughput Screening
11%
Phosphotransferase
11%
Drug Resistance
8%
Adverse Event
8%
Anticarcinogen
7%
Cross-Validation
7%
Survival
5%
Leukemia
5%
Tumor Growth
5%
Metastasis
5%
Phosphotransferase Inhibitor
5%
Dopamine Receptor
5%
Ligand
5%
Biochemistry, Genetics and Molecular Biology
Molecule
22%
Clinical Trial
15%
Immune Response
11%
Species
11%
Regulatory Mechanism
11%
Nested Gene
11%
Anticancer
11%
Reconstruction
11%
Data Base
11%
Learning
11%
Drug Targeting
11%
Computer Model
11%
Pharmacophore
11%
Docking (Molecular)
11%
Binding Site
11%
Drug Resistance
11%
Phosphotransferase
11%
Kinase
11%
Dopamine Receptor
11%
Development
9%
Survival Rate
5%
Reprogramming
5%
Solution and Solubility
5%
Medicine and Dentistry
Chemotherapeutic Agent
33%
Drug
33%
Drug Repositioning
22%
Screening
22%
Virtual Screening
22%
In Silico
18%
Development
13%
Adverse Drug Reaction
11%
Src Inhibitor
11%
Lead
11%
Adverse Event
8%
Combination Therapy
8%
Multifactorial Disease
5%
Molecular Methodology
5%
Dopamine Receptor
5%
Learning
5%
Drug Resistance
5%